Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cultured human corneal endothelial cell transplantation for Fuchs endothelial corneal dystrophy
TCTR20250109003Phase 2Not yet recruiting
- Sponsor
- National Science, Research and Innovation Fund
- Start
- Jun 2025
- Modality
- Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of neltependocel, Y-27632 in Fuchs endothelial dystrophy (FED), sponsored by National Science, Research and Innovation Fund. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
neltependocelY-27632
03
Conditions
Fuchs endothelial dystrophy (FED)
Beyond the preview
Go deeper on TCTR20250109003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250109003.